ReviewCancers2021

Resistance to Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia-From Molecular Mechanisms to Clinical Relevance.

Raquel Alves et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.